arrow_back Back Filing freshness 10-Q Q1 FY2027 SEC EDGAR

download Export Data

InMed Pharmaceuticals Inc.

INM

$15.21 ▲ +13.41 (+745.00%) at close

30 Visible periods

29 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, InMed Pharmaceuticals Inc. shows weak fundamentals, weighed down by FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $83.2M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC None

FCF / Share $-0.21

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

30-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$820.19K

↓ -26.2% —

Net Income Profit after all expenses

$-2.33M

↓ -35.0% —

Operating Margin Operating profit as % of sales

-281.3%

↓ -45.6% —

FCF / Share Free cash flow per share

$-0.21

↑ +48.6% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

FCF / Net IncomeFCF / Net Income of 0.69x is weak on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	Q1 FY2027 Sep 30, 2026 10-Q ↗	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q1 FY2020 Sep 30, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗
Revenue Growth YoY (%)	—	—	—	-26.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-428%)	-11.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-243%)	—	7.6% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-5%)	-10.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-230%)	40.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+403%)	-44.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-656%)	13.4% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+68%)	164.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1950%)	181.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2164%)	349.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4262%)	234.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2825%)	77.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+865%)	—	-41.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-619%)	-29.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-465%)	-4.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-153%)	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	4.5% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-232.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	62.4% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	86.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	83.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	88.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	45.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-1815.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-256.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	-496.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	79.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	81.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-35.0% Weak ↑ Weak Improving Year-over-year change in net income	-226.5% Weak ↓ Weak Declining Year-over-year change in net income	-2.9% Weak ↓ Weak Declining Year-over-year change in net income	-2.9% Weak ↓ Weak Declining Year-over-year change in net income	-2.9% Weak ↓ Weak Declining Year-over-year change in net income	7.7% Fair ↓ Fair Declining Year-over-year change in net income	33.9% Excellent ↑ Excellent Improving Year-over-year change in net income	33.9% Excellent ↑ Excellent Improving Year-over-year change in net income	33.9% Excellent ↑ Excellent Improving Year-over-year change in net income	17.1% Good ↑ Good Improving Year-over-year change in net income	-27.0% Weak ↓ Weak Declining Year-over-year change in net income	27.7% Excellent ↓ Excellent Declining Year-over-year change in net income	27.7% Excellent ↓ Excellent Declining Year-over-year change in net income	79.4% Excellent ↑ Excellent Improving Year-over-year change in net income	42.5% Excellent ↑ Excellent Improving Year-over-year change in net income	18.0% Good ↑ Good Improving Year-over-year change in net income	-18.1% Weak ↑ Weak Improving Year-over-year change in net income	-248.2% Weak ↓ Weak Declining Year-over-year change in net income	-12.1% Weak ↑ Weak Improving Year-over-year change in net income	-90.9% Weak ↓ Weak Declining Year-over-year change in net income	-85.8% Weak ↓ Weak Declining Year-over-year change in net income	-101.6% Weak ↓ Weak Declining Year-over-year change in net income	-53.2% Weak ↓ Weak Declining Year-over-year change in net income	10.0% Fair Fair Year-over-year change in net income	43.0% Excellent Excellent Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	48.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	86.2% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-350.9% Weak Weak Year-over-year change in free cash flow	—	-708.5% Weak Weak Year-over-year change in free cash flow	—	74.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	20.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	51.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	—	59.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	61.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	—	13.4% Good ↓ Good Declining Compound annual revenue growth over 3 years	38.9% Excellent Excellent Compound annual revenue growth over 3 years	64.9% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	—	—	—	24.3% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2027 Sep 30, 2026 10-Q ↗	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q1 FY2020 Sep 30, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	-281.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1975%)	—	-193.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1388%)	-447.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3082%)	—	—	—	—	—	-370.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2567%)	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	-210.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1855%)	-154.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1385%)	—	-133.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1208%)	-150.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1358%)	-132.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1206%)	-151.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1358%)	-216.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1903%)	-204.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1805%)	-281.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2444%)	-101.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-942%)	-193.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1710%)	—	—	—	—	—	—	-370.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3184%)	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	-250.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-143.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	-144.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-80.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-165.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	—	-241.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-28.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-160.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	-227.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.49x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.19x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.18x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.86x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.28x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.36x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.89x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.49x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2027 Sep 30, 2026 10-Q ↗	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q1 FY2020 Sep 30, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗
Return on Invested Capital (%)	—	—	—	—	—	—	—	—	—	—	—	—	-20.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	—	-12.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-25.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-68.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-23.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	—	-34.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-23.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—
Return on Capital (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	-23.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-13.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-61.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-33.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	194.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1196%)	—	-25.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-267%)	-18.0% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-220%)	-14.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-199%)	-13.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-189%)	-23.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-259%)	-27.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-281%)	-20.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-233%)	-21.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-240%)	-22.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-252%)	-19.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-232%)	-26.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-277%)	-19.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-229%)	-16.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-208%)	-24.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-263%)	-31.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-313%)	-125.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-933%)	-31.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-313%)	-30.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-302%)	-19.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-230%)	-44.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-395%)	-29.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-299%)	-29.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-297%)	-35.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-337%)	-27.5% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-283%)	-28.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-291%)	-25.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-273%)	-24.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-263%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2027 Sep 30, 2026 10-Q ↗	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q1 FY2020 Sep 30, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-99%)	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-1331.96x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-700.36x Weak Weak Operating income divided by interest expense Optimal: > 5x	-516.21x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	-6.23x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—
Net Debt (USD)	—	—	$-5.16M	$-6.95M	$-9.33M	—	$-4.68M	$-3.42M	$-5.58M	$-6.57M	—	$-9.53M	$-6.74M	$-8.91M	$-9.60M	$-11.45M	$-9.35M	$-6.18M	$-5.87M	$-11.22M	$-15.34M	$-7.36M	—	—	$-4.50M	$-5.81M	—	—	—	$-9.84M
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.01x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.01x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2027 Sep 30, 2026 10-Q ↗	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q1 FY2020 Sep 30, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗
Revenue per Share (USD)	—	—	—	$0.21	$0.28	—	$1.15	$1.57	$2.04	—	$2.44	$0.16	$0.27	—	$0.31	$0.20	$0.37	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.42	$-1.43	$-0.73	$-0.51	$-0.44	$-0.43	$-1.94	$-3.64	$-2.71	$-3.66	$-3.58	$-0.19	$-0.76	$0.28	$-0.60	$-0.91	$-4.06	$-13.04	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.21	—	$-0.42	$-0.52	$-0.41	—	—	—	$-2.95	—	$-4.02	—	$-0.65	—	$-0.50	—	$-2.61	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-0.22	$0.20	$2.08	$3.42	$4.45	$6.71	$5.82	$8.54	$12.59	$20.65	$23.10	$2.25	$2.88	$3.63	$3.72	$9.02	$12.11	$13.95	$0.76	$1.00	$1.47	$22.91	—	—	$0.86	$1.13	—	—	—	—
Tangible Book Value per Share (USD)	$-0.22	$0.20	$1.63	$2.87	$3.84	$5.90	$4.44	$6.19	$9.97	$16.65	$23.10	$1.92	$2.88	$3.05	$3.13	$7.74	$9.84	$10.71	$0.46	$0.69	$1.37	$19.61	—	—	$0.65	$0.92	—	—	—	—
Basic Weighted Avg Shares (shares)	5.47M	—	4.05M	3.95M	3.95M	—	1.10M	706,546	620,127	—	480,649	7.97M	3.33M	—	3.33M	2.30M	865,619	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2027 Sep 30, 2026 10-Q ↗	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q1 FY2020 Sep 30, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗
Working Capital (USD)	—	$721.65K	$4.68M	$7.31M	$9.24M	$11.03M	$4.57M	$3.68M	$5.84M	$6.72M	—	$10.13M	$6.96M	$9.33M	$9.57M	$11.62M	$8.26M	$6.28M	$4.64M	$7.89M	$14.05M	$6.16M	—	—	$3.24M	$4.64M	—	—	—	—
Total Equity (USD)	$-1.20M	$1.08M	$6.89M	$9.59M	$11.59M	$13.43M	$7.02M	$6.18M	$8.40M	$9.21M	$11.10M	$12.77M	$9.58M	$12.09M	$12.39M	$14.34M	$11.01M	$9.08M	$10.89M	$14.17M	$15.22M	$7.38M	$10.41M	$7.59M	$4.49M	$5.88M	$7.07M	$9.61M	$11.47M	$14.24M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2027 Sep 30, 2026 10-Q ↗	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q1 FY2020 Sep 30, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	$820.19K	$1.12M	—	$1.26M	$1.11M	$1.26M	$1.28M	$1.17M	$1.24M	$901.86K	$2.31M	$1.03M	$469.78K	$320.79K	$514.76K	$309.58K	$265.09K	—	$880.63K	$437.31K	$276.79K	—	—	—	—	—	—
Depreciation Expense (USD)	$168.00	$48.36K	$50.51K	$53.20K	$53.20K	$52.75K	$12.20K	$12.21K	$54.58K	$54.77K	$54.77K	$14.24K	$54.83K	$53.46K	$50.69K	—	$49.05K	$53.99K	—	—	$28.53K	$28.65K	$27.42K	$36.82K	$27.98K	$26.86K	$27.11K	$28.23K	$30.23K	—
Net Income, GAAP (USD)	$-2.33M	$-5.84M	$-1.73M	$-1.73M	$-1.73M	$-1.79M	$-1.68M	$-1.68M	$-1.68M	$-1.94M	$-2.54M	$-2.54M	$-2.54M	$-2.34M	$-2.00M	$-3.51M	$-3.51M	$-11.35M	$-3.48M	$-4.28M	$-2.97M	$-3.26M	$-3.10M	$-2.24M	$-1.60M	$-1.62M	$-2.02M	$-2.49M	$-2.81M	—
Operating Cash Flow (USD)	$-1.14M	$-2.96M	$-1.70M	$-2.05M	$-1.61M	$-2.11M	—	—	$-1.83M	$-1.03M	$-1.93M	—	$-2.17M	$-657.93K	$-1.66M	—	$-2.26M	$-4.05M	—	—	$-2.65M	$-2.01M	$-4.61M	$-1.80M	$-1.37M	$-1.40M	$-1.52M	$-2.09M	$-2.37M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 8 years · 30 quarters

InMed Pharmaceuticals Inc.

Analytical Summary

30-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare INM with peers